| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/01/2004 | US6743795 Inhibitors for hepatitis b and acquired immune deficiency syndrome (aids) because they interfere with removal of rna strand from rna-dna hybrid formed during the reverse transcription of viral rna to dna |
| 06/01/2004 | US6743793 Dp receptor antagonist; prostaglandin d |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743787 For therapy of metabolic disorders mediated by insulin resistance or hyperglycemia in a mammal |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | CA2279943C Treatment of skin disorders |
| 06/01/2004 | CA2266016C Tricyclic inhibitors of farnesyl protein transferase |
| 05/29/2004 | WO2004035566A1 Cannabinoid receptor ligands and uses thereof |
| 05/29/2004 | CA2502511A1 Cannabinoid receptor ligands and uses thereof |
| 05/27/2004 | WO2004043966A1 New tricyclic derivatives as ltd4 antagonists |
| 05/27/2004 | WO2004043952A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
| 05/27/2004 | WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors |
| 05/27/2004 | WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | WO2004043949A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 05/27/2004 | WO2004043948A1 Sulfonamides |
| 05/27/2004 | WO2004043947A1 Novel pyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/27/2004 | WO2004043936A1 Plk inhibitors |
| 05/27/2004 | WO2004043930A1 Quinoline derivatives which enhance cognition via the gaba-a receptor |
| 05/27/2004 | WO2004043929A1 Quinoline derivatives |
| 05/27/2004 | WO2004043928A2 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents |
| 05/27/2004 | WO2004043927A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 05/27/2004 | WO2004043926A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors |
| 05/27/2004 | WO2004043917A1 Sulfonamides |
| 05/27/2004 | WO2004043899A1 4-aminomethyl-1-aryl-cyclohexylamine derivatives |
| 05/27/2004 | WO2004043463A2 Sulfonamides |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043389A2 Methods of treating cancer and related methods |
| 05/27/2004 | WO2004043379A2 Chemical compounds |
| 05/27/2004 | WO2004043369A2 Sulfonamides |
| 05/27/2004 | WO2004043366A2 Sulfonamides |
| 05/27/2004 | WO2004043354A2 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043339A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 05/27/2004 | WO2004043337A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 05/27/2004 | WO2004032908A9 Method of inhibiting angiogenesis |
| 05/27/2004 | WO2004031160A3 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 05/27/2004 | WO2004004725A3 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
| 05/27/2004 | WO2003002109A3 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 05/27/2004 | WO2002065977A8 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102511 HMG-CoA reductase inhibitors; anticholesterol; statins; potency greater than atorvastatin; amidation of the b-keto ester with an amine, reaction with an aldehyde; cyclization |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102492 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 05/27/2004 | US20040102489 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102487 N-substituted tetrahydropyridines and their use as pesticides |
| 05/27/2004 | US20040102484 Prodrugs of proton pump inhibitors |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102481 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 05/27/2004 | US20040102478 Alzheimer's and Parkinson's disease; antiinflamamtory agents; antiallergens; vision defects |
| 05/27/2004 | US20040102474 Dietetics; antidiabetic agents; eating disorders |
| 05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
| 05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
| 05/27/2004 | US20040102457 Central nervous system disorders; anxiolytic agents; antidepressants; attention deficit disorders; Alzheimer's diseases |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102453 Antiproliferative agents |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505873A1 Quinoline derivatives |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | CA2505491A1 New tricyclic derivatives as ltd4 antagonists |
| 05/27/2004 | CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | CA2505127A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | CA2503993A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
| 05/26/2004 | EP1422227A1 Process for producing pyridine compound |
| 05/26/2004 | EP1422219A1 Cyclic amine compound |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1421077A2 Novel pyrazole analogs acting on cannabinoid receptors |
| 05/26/2004 | EP1421076A1 Hydrates of optionally substituted 2-(2-pyridinyl)methylthio-1h-benzimidazoles and method for the production thereof |
| 05/26/2004 | EP1421075A1 Piperidine derivatives useful as ccr5 antagonists |
| 05/26/2004 | EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420791A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420781A2 Analgetic pyrroline derivatives |